Fig. 3
Proton-pump inhibitor dispensation prevalence by sex from 2002 to 2015 (%): a) omeprazole; b) pantoprazole; c) lansoprazole; d) rabeprazole; e) esomeprazole
Fig. 3 | BMC Public Health
Proton-pump inhibitor dispensation prevalence by sex from 2002 to 2015 (%): a) omeprazole; b) pantoprazole; c) lansoprazole; d) rabeprazole; e) esomeprazole